Generative AI in Healthcare Market Analysis
Based on application, the generative AI in healthcare market is classified into personalized treatment, patient assistance, patient monitoring & predictive analytics, medical image analysis & diagnostics, drug discovery & development and other applications. The medical image analysis and diagnostics segment is expected to dominate, contributing significantly to revenue of USD 612.7 million in 2023 and poised to exhibit dominance throughout the forecast period.
- Generative AI rendered a remarkable progress in medical imaging analysis that transformed the diagnostic and treatment approaches.
- Leveraging generative AI enhanced the image quality, refined the disease detection, and customized the treatment plans for patients. For instance, techniques such as generative adversarial networks (GANs) employed to boost the quality and resolution of medical images. Comprising a generator creating synthetic images and a discriminator evaluating authenticity, GANs exemplified the generative AI that reshaped the landscape of medical imaging, offering potential advancements in precision, diagnostics, and personalized healthcare.
- Thus, the market growth has been propelled by the prominent advantage of generative AI in image analysis and diagnostics, showcasing its pivotal role in advancing and shaping the healthcare industry.
Based on end-use, the generative AI in healthcare market is classified into healthcare providers, pharmaceutical and life science companies, and healthcare payers. In 2023, the healthcare providers segment is expected to reach USD 11.8 billion by 2032.
- Healthcare providers, including hospitals, clinics, and diagnostic centers, emerged as dominant players in the generative AI in healthcare market. Their prominence is attributed to leveraging generative AI to streamline medical processes, enhance diagnostics, and optimize patient care. Also, the application of generative AI technologies within these healthcare settings has led to improved efficiency, accuracy in diagnostics, and overall advancements in healthcare delivery, establishing healthcare providers as key drivers of innovation and progress in the evolving landscape of healthcare technology.
In 2023, North America secured a substantial market share in the global generative AI in healthcare market and is expected to dominate throughout the forecast period.
- The dominance is boosted by the robust technological landscape and a well-established healthcare infrastructure, fostering a conducive environment for the adoption and integration of advanced AI solutions.
- Substantial investments in R&D, supported by both government and private sectors, drive the rapid growth of generative AI applications. The region hosts leading research institutions and AI-focused tech companies, fostering an innovative ecosystem.
- Further, emphasizing healthcare efficiency and precision medicine, North America's intensified interest in generative AI solidifies its pivotal role and prominence in shaping the trajectory of this technology within the healthcare sector.